RESTASIS ® Ophthalmic Emulsion contains cyclosporine. How does this affect the safety profile of RESTASIS ®?

RESTASIS ® Ophthalmic Emulsion has a favorable safety profile. In fact, in clinical studies, there was no increase in infection, interaction with other drugs, increase in intraocular pressure, or detectable systemic drug absorption in the blood for up to 12 months of treatment. The delivery vehicle for cyclosporine in RESTASIS ® is a unique, oil-based ophthalmic emulsion.

This emulsion technology provides effective drug delivery to ocular tissue and is effective with a very low cyclosporine concentration (0.05%). More.

I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.